NCT01549002View on ClinicalTrials.gov

Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children

PHASE3CompletedINTERVENTIONAL

Enrollment

Participants

Timeline

Start Date

January 31, 2012

Primary Completion Date

April 30, 2013

Study Completion Date

April 30, 2013

Conditions

AbscessPain

Interventions

DRUG

Intranasal Fentanyl

Drug: Fentanyl 50 micrograms/mL Dosage: 2 micrograms per kilogram (maximum 100 micrograms) Drug delivery: Intranasal via mucosal atomization device (MAD® Nasal, Wolfe Tory Medical Inc., Salt Lake City, UT) Frequency: one-time dose

DRUG

Intravenous Morphine

Drug: Morphine Dosage: 0.1 milligrams/kilogram (maximum 8 milligrams) Drug delivery: Slow IV push Frequency: one-time dose

Trial Locations (1)

10032

Alexandra & Steven Cohen Children's Emergency Department of Columbia University Medical Center, New York

All Listed Sponsors

lead

Columbia University

OTHER

NCT01549002 - Efficacy of Intranasal Fentanyl at Reducing Pain During Abscess Incision and Drainage (I&D) in Children | Biotech Hunter | Biotech Hunter